MCAC Referral Draft Guidelines Need Clarity, More Specificity – AdvaMed
This article was originally published in The Gray Sheet
Guidelines specifying how the public can best frame evidentiary questions used in MCAC review should be included in a 1CMS draft guidance stipulating criteria for when an NCD should be referred to the committee, AdvaMed maintains
You may also be interested in...
Industry reps plan to hold a conference call within the next several weeks to discuss a 1CMS draft guidance stipulating criteria for when national coverage determinations should be referred for external review or to the Medicare Coverage Advisory Committee
Guidant's subgroup analysis demonstrating that non-inducible EP-tested patients showed lower mortality rates with ICDs over conventional therapy played a decisive factor in MCAC's endorsement of national coverage
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.